Article Information
History
- June 2, 2020.
Article Versions
- Version 1 (May 30, 2020 - 18:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew P. Crotty1,*,
- Ronda Akins2,
- An Nguyen2,
- Rania Slika3,
- Kristen Rahmanzadeh1,
- Marie H. Wilson4 and
- Edward A. Dominguez5
- 1Department of Pharmacy, Methodist Dallas Medical Center, Dallas, Texas, USA
- 2Department of Pharmacy, Methodist Charlton Medical Center, Dallas, Texas, USA
- 3Department of Pharmacy, Methodist Mansfield Medical Center, Dallas, Texas, USA
- 4Infection Prevention and Control, Methodist Dallas Medical Center, Dallas, Texas, USA
- 5Organ Transplant Infectious Diseases, Methodist Transplant Specialists, Methodist Dallas Medical Center, Dallas, Texas, USA
- ↵*Correspondence to:
Matthew Crotty, Department of Pharmacy, Methodist Dallas Medical Center, Dallas, Texas, USA. E-mail: matthewcrotty{at}MHD.com, tel: 214-963-7252
Posted June 02, 2020.
Investigation of subsequent and co-infections associated with SARS-CoV-2 (COVID-19) in hospitalized patients
